Literature DB >> 32223687

Practical guidance for using the FreeStyle Libre flash continuous glucose monitoring in primary care.

Jeff Unger1, Pamela Kushner2, John E Anderson3.   

Abstract

Use of continuous glucose monitoring (CGM) improves clinical outcomes in type 1 diabetes, and significant benefits been demonstrated in patients with type 2 diabetes, including improved glycemic control, better treatment adherence, and an increased understanding of their treatment regimens. Currently, there are two types of CGM systems: real-time CGM (rtCGM) and flash CGM (FCGM). Retrospective analysis of CGM data allows patients and their clinicians to identify glycemic patterns that support and facilitate informed therapy decisions. With the increasing prevalence of diabetes, primary care physicians will be compelled to take on more responsibility for managing patients with diabetes. This article focuses on practical approaches and decision-making strategies for utilizing FCGM in primary care settings.

Entities:  

Keywords:  CGM; Continuous glucose monitoring; FCGM; flash monitoring; time below range; time in range; type 1 diabetes; type 2 diabetes

Year:  2020        PMID: 32223687     DOI: 10.1080/00325481.2020.1744393

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  3 in total

1.  A Telehealth Diabetes Intervention for Rural Populations: Protocol for a Randomized Controlled Trial.

Authors:  Michelle L Litchman; Bethany M Kwan; Linda Zittleman; Juliana Simonetti; Eli Iacob; Kristen Curcija; Julie Neuberger; Gwen Latendress; Tamara K Oser
Journal:  JMIR Res Protoc       Date:  2022-06-14

2.  FreeStyle Libre Flash Glucose Monitoring system for people with type 1 diabetes in the UK: a budget impact analysis.

Authors:  Robert Blissett; Deirdre Blissett; Fleur Levrat-Guillen; Harshal Deshmukh; Emma G Wilmot; Robert E J Ryder; Chris Walton; Thozhukat Sathyapalan
Journal:  BMJ Open Diabetes Res Care       Date:  2022-03

3.  Long-term follow-up of a randomized clinical trial comparing glycemic excursion minimization (GEM) to weight loss (WL) in the management of type 2 diabetes.

Authors:  Daniel J Cox; Tamara Oser; Matthew Moncrief; Mark Conaway; Anthony McCall
Journal:  BMJ Open Diabetes Res Care       Date:  2021-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.